DekaBank Deutsche Girozentrale’s Cytokinetics CYTK Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-57,500	Closed	-$4.46M	–	1176
2025 Q4	$4.46M	Hold	57,500	–	–	0.01%	606
2025 Q3	$3.07M	Hold	57,500	–	–	0.01%	674
2025 Q2	$1.9M	Hold	57,500	–	–	﹤0.01%	750
2025 Q1	$2.45M	Hold	57,500	–	–	﹤0.01%	695
2024 Q4	$2.67M	Hold	57,500	–	–	﹤0.01%	696
2024 Q3	$2.98M	Hold	57,500	–	–	0.01%	682
2024 Q2	$3.07M	Hold	57,500	–	–	0.01%	677
2024 Q1	$4.13M	Sell	57,500 -17,500	-23%	-$1.35M	0.01%	618
2023 Q4	$6.13M	Buy	75,000 +20,000	+36%	+$724K	0.01%	541
2023 Q3	$1.69M	Hold	55,000	–	–	﹤0.01%	778
2023 Q2	$1.79M	Buy	55,000 +11,000	+25%	+$407K	﹤0.01%	773
2023 Q1	$1.37M	Sell	44,000 -12,100	-22%	-$494K	﹤0.01%	803
2022 Q4	$2.52M	Hold	56,100	–	–	0.01%	673
2022 Q3	$2.72M	Hold	56,100	–	–	0.01%	643
2022 Q2	$2.35M	Hold	56,100	–	–	0.01%	686
2022 Q1	$2.05M	Buy	56,100 +5,100	+10%	+$181K	0.01%	746
2021 Q4	$2.35M	Buy	51,000 +1,400	+3%	+$54K	0.01%	732
2021 Q3	$1.66M	Buy	49,600 +25,000	+102%	+$736K	﹤0.01%	766
2021 Q2	$513K	Hold	24,600	–	–	﹤0.01%	1064
2021 Q1	$544K	Hold	24,600	–	–	﹤0.01%	1013
2020 Q4	$505K	Sell	24,600 -56,200	-70%	-$1.03M	﹤0.01%	1017
2020 Q3	$1.77M	Buy	+80,800	New	+$1.89M	0.01%	617

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DekaBank Deutsche Girozentrale's CYTK Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 57,500 shares — an estimated $4.46M sold.

DekaBank Deutsche Girozentrale first reported a position in CYTK in Q3 2020 and held it in 22 quarters. The position peaked at $6.13M in Q4 2023. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 57,500 Cytokinetics shares in Q1 2026, an estimated $4.46M.
DekaBank Deutsche Girozentrale first reported a position in Cytokinetics in Q3 2020 and held it in 22 quarters.
DekaBank Deutsche Girozentrale's Cytokinetics position peaked at $6.13M in Q4 2023.
440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.